PMEL and melanoma: In all cases, immune composition analysis of tumors following the second immunotherapy indicated treated mice across all immunotherapies show massive immune-cell and T-cell infiltration (Figure 1C) with a dominant representation of T-cell clones against the melanoma antigens TRP2 and gp100 (Figure 1D).